This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thomas Mandel Clausen and His Antiviral Glycosidase Patent
Introduction
Thomas Mandel Clausen is an inventor associated with La Jolla, California, and the University of California. His patent work explores how enzymes that modify glycans may help address viral infections.
Latest Patents
Clausen is associated with 1 patent: “Application of Microbial Glycosidase as an Anti-Viral Therapeutic, Prognostic, and Diagnostic.” The patent describes methods and compositions for diagnosing, preventing, or treating viral infections by administering a glycosidase or sulfatase to degrade glycans, including heparan sulfate, and inhibit infection. It also covers approaches to identifying enzymes or microbes associated with increased susceptibility to viral infection.
Career Highlights
Clausen’s listed patent reflects research at the intersection of microbial enzymes, glycans, and antiviral strategies. The disclosed methods include potential applications to infections such as COVID-19.
Collaborations
Clausen’s listed coworker is Robin Knight. His company affiliation is the University of California.
Conclusion
Thomas Mandel Clausen’s patent focuses on using glycosidases and sulfatases to investigate and potentially inhibit viral infections, highlighting an innovative approach to antiviral research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile